The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 08, 2015
Filed:
Apr. 23, 2008
Applicants:
Neil Riordan, Tempe, AZ (US);
Fabio Salazar, San Jose, CR;
Thomas E. Ichim, San Diego, CA (US);
Inventors:
Assignee:
Creative Medical Health, Inc., Phoenix, AZ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 31/00 (2006.01); A61K 31/34 (2006.01); C12N 5/00 (2006.01); C12N 5/06 (2006.01); C12N 5/08 (2006.01); A61K 35/34 (2015.01); A61K 35/28 (2015.01); A61K 35/44 (2015.01); A61K 38/44 (2006.01); A61K 45/06 (2006.01); A61K 31/05 (2006.01); A61K 31/203 (2006.01); A61K 31/366 (2006.01); A61K 31/375 (2006.01); A61K 31/385 (2006.01); A61K 31/519 (2006.01); A61K 31/7048 (2006.01); C12N 5/07 (2010.01); C12N 5/078 (2010.01);
U.S. Cl.
CPC ...
A61K 35/34 (2013.01); A61K 31/05 (2013.01); A61K 31/203 (2013.01); A61K 31/366 (2013.01); A61K 31/375 (2013.01); A61K 31/385 (2013.01); A61K 31/519 (2013.01); A61K 31/7048 (2013.01); A61K 35/28 (2013.01); A61K 35/44 (2013.01); A61K 38/446 (2013.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01); C12N 5/06 (2013.01); C12N 5/0634 (2013.01);
Abstract
Disclosed are methods, compositions of matter and cells for treatment of cardiovascular disease through concurrent inhibition of oxidative stress while administration of a cell therapy. The invention also concerts the modulation of oxidative stress for preferential induction of differentiation while concurrently inhibiting inflammatory processes that decrease efficacy of cellular therapy.